Revision Facelift in Scottsdale

What the Evidence Shows

Data specific to secondary facelift are limited to retrospective single-surgeon series and expert reviews, so the numbers below are directional. They consistently show that revision surgery is technically harder than a first facelift, and that its outcomes depend on preoperative analysis and command of the anatomy rather than on a technique name.

• In seventy reoperative sub-SMAS facelifts, altered SMAS and platysma anatomy was found in 82.9 percent of cases, temporary facial nerve weakness occurred in 7.1 percent compared with 2.2 percent of primary cases, and no permanent nerve injury was reported. The revision rate within eighteen months was 11.4 percent.
• A matched comparison of primary and secondary rhytidectomy found the SMAS graded roughly one third as thick in secondary patients and the average skin resection 17.6 mm versus 26.6 mm, with one hematoma and one hypertrophic scar among twenty-one secondary patients, all of whom were satisfied.
• A twenty-year, 811-facelift experience found the average interval from primary to secondary surgery was 9.0 years and from secondary to tertiary 7.5 years, with no difference in longevity, and an overall secondary complication rate near two percent.
• Comprehensive reviews of secondary rhytidectomy emphasize distinguishing stigmata of the first operation, such as pixie ear, hairline displacement, and over-lateralized vectors, from natural aging, and describe a framework of resecting scar, releasing abnormal SMAS vectors, refilling volume with fat, reshaping the deeper layer, and redraping less skin.
• Across all facelift techniques, pooled meta-analysis reports temporary motor nerve injury in well under one percent and permanent injury in about one in two thousand, and deep-plane dissection does not raise permanent nerve injury rates, which frames the revision-specific numbers above.
• Magnetic resonance imaging of thirty-three midface filler patients found hyaluronic acid still present in every patient two to five years after injection and in some patients up to fifteen years, and a case series documented persistence at twenty-seven months without migration in the lateral face and midface.
• In a survey of aesthetic surgeons, 51.9 percent reported that a history of panfacial filler increased the difficulty of facelift surgery, 39.7 percent believed it raised complication rates, and the most cited problems were palpable or visible filler and compromised flap vascularity.
• A retrospective review of 212 deep plane facelifts found 57 percent of patients had prior injectables and no statistically significant difference in complication rates between the two groups, and a twenty-patient pilot cohort reported no complications attributable to prior filler or biostimulators.
• A 2025 expert consensus on facelift after minimally invasive treatments classified biostimulatory injectables, temporary fillers, and superficial energy devices as generally lower risk, and permanent fillers, deeply delivered energy devices, and recently placed temporary fillers or threads as higher risk, with perioperative strategies aimed at plane distortion and vascular compromise.
• In a series of ten facelifts after two or more absorbable thread procedures, every case showed fibrosis, tissue distortion, fusion of the anatomic layers, and decreased SMAS mobility; seven patients had dimpling or suboptimal redraping and one had temporary marginal mandibular weakness. A review of 552 facelifts found 207 patients with prior minimally invasive treatments, and scar from threads or energy devices, cheek fat atrophy, and large-volume injectables each forced a modified plan.
• In a 2026 survey of 63 facial surgeons on collagen biostimulators, 91.8 percent reported difficulty in tissue dissection, 73.3 percent postoperative skin irregularities, and 50.8 percent longer operative times, with threads and calcium hydroxylapatite the products most often recognized at surgery and procedures within six months of injection judged most challenging. A 2026 systematic review of 1,410 patients found hyaluronic acid persistence of fifty to eighty-six percent at twenty-four months on volumetric assessment.
• Cadaver dissection of fifty heads shows the facial nerve branches lie embedded within the deep fascia rather than deep to it, so deep plane dissection must stay at its most superficial layer; fibrosis from threads, biostimulators, or prior surgery removes the cues that normally mark that boundary.
• Systematic reviews of thread lifts published in 2018, 2021, and 2025 conclude that the immediate lift is real and dangerous complications are uncommon, but that durability is at best limited and long-term efficacy data are lacking, with the most favorable early studies sponsored by thread manufacturers.
• A matched series of sixteen cervicofacial rhytidectomies after head and neck radiotherapy found surgery feasible but with more serious complications, and identified subcutaneous facelift technique and concurrent chemotherapy as associated with complications. An earlier series of eleven facelifts after head and neck tumor removal reported no major complications, with small incision-line dehiscences occurring only in patients who had received radiation.
• Cadaver perfusion studies show the transverse facial artery perforator supplies the lateral facelift flap and that a composite sub-SMAS flap perfuses the preauricular skin better than a subcutaneous dissection, and a 407-facelift series with a third of patients smoking reported no skin slough with conservative undermining. Together these support deep plane dissection with limited skin undermining wherever the skin circulation is compromised.
• Facial plastic surgery reviews of poor wound healing list prior irradiation, nicotine and e-cigarette use, chronic steroids, diabetes, and malnutrition as the risk factors to screen for before facial surgery, and describe the altered vascular and fibroblast biology of irradiated tissue that underlies delayed healing.